clofazimine has been researched along with Granuloma Annulare in 1 studies
Clofazimine: A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619)
clofazimine : 3-Isopropylimino-3,5-dihydro-phenazine in which the hydrogen at position 5 is substituted substituted by a 4-chlorophenyl group, and that at position 2 is substituted by a (4-chlorophenyl)amino group. A dark red crystalline solid, clofazimine is an antimycobacterial and is one of the main drugs used for the treatment of multi-bacillary leprosy. However, it can cause red/brown discolouration of the skin, so other treatments are often preferred in light-skinned patients.
Granuloma Annulare: Benign granulomatous disease of unknown etiology characterized by a ring of localized or disseminated papules or nodules on the skin and palisading histiocytes surrounding necrobiotic tissue resulting from altered collagen structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a case of Sweet's syndrome in association with generalized granuloma annulare (GA) which presented 3 years after a diagnosis of breast carcinoma." | 1.31 | Sweet's syndrome in association with generalized granuloma annulare in a patient with previous breast carcinoma. ( Antony, F; Holden, CA, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antony, F | 1 |
| Holden, CA | 1 |
1 other study available for clofazimine and Granuloma Annulare
| Article | Year |
|---|---|
Sweet's syndrome in association with generalized granuloma annulare in a patient with previous breast carcinoma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Clofazimine; Estrogen Antagonists; Female | 2001 |